Pioneering Solutions against Bacterial Resistance

Da Volterra is a privately-held biotech company, headquartered in Paris, France. It is committed to the discovery and development of innovative approaches addressing the control of the emergence and dissemination of resistance to antimicrobials, corresponding to largely unmet medical needs.

Da Volterra’s mission is to allow clinicians to envision "eco-responsible antibiotherapies", by developing unique breakthrough innovations to tackle the worldwide dramatic issues raised by the resistance to antibiotics, through the application of its proprietary technologies. Led by an experienced team, Da Volterra has core know-how in Microbiology, Drug delivery, Pharmacology, Pharmaceutical and Clinical Development.

Da Volterra’s ambition is to build and develop efficiently a diverse portfolio of drug candidates from Research to Clinical proof of concept, and to propose innovative solutions to the community which is often powerless when facing the consequences of bacterial resistance.

Da Volterra’s strategy involves partnering its programs at different stages of R&D with companies able to further co-develop and market its products.

 KEY FACTS